Advisory OTCs? GSK Discusses “Third Class” Drug Paradigm, But Xenical Not Included

GSK Consumer Healthcare’s Regnier says firm is discussing pharmacy-only class internally but has yet to take a formal stance on the issue. Any switch of the weight-loss drug orlistat would occur within the existing two-class system, the company says.